This comment is not public.
Thierry Voet is Full Professor in the Faculty of Medicine at KU Leuven, where he is affiliated with the Department of Human Genetics. He heads the Laboratory of Reproductive Genomics and serves as Director of the KU Leuven Institute for Single Cell Omics (LISCO), which he founded in 2021 together with 33 colleagues. Voet also leads the Division LISCO-BIOMED, the Subdivision LISCO-BIOMED, and the Subdivision TV - LISCO-BIOMED, and he is a member of the KU Leuven Cancer Institute. His career at KU Leuven began with a tenure track appointment as Associate Professor in 2014, followed by promotion to tenured Professor in 2017 and Full Professor in 2022.
Voet holds a Master’s degree in Bioscience Engineering: Cell and Gene Biotechnology and an inter-university postgraduate degree in Human Genetics from KU Leuven. He completed his PhD in Medical Sciences at KU Leuven’s Human Genome Laboratory, where he pioneered single-cell microarray analyses. In 2010, he joined the Cancer Genome Project at the Wellcome Sanger Institute as a visiting researcher, later becoming an Associate Faculty Member, Group Leader, and co-founder of the Sanger-EBI Single-Cell Genomics Centre. Voet’s research centers on the development of single-cell and spatial multi-omics methods to characterize DNA and RNA in individual cells, enabling studies of mutagenesis, somatic genetic heterogeneity, and their impacts on disease. These approaches are applied to investigate cellular heterogeneity in human development, aging, reproductive processes, cancer evolution, and neurological conditions such as Parkinson’s disease. Key publications include “Mutational Processes Shaping the Genome in Early Human Embryos” (Cell, 2017) and the development of G&T-seq for parallel sequencing of single-cell genomes and transcriptomes. In 2025, Voet was named a Highly Cited Researcher.
